Clinical outcome in patients with small intestinal non-Hodgkin lymphoma

Shinichi Kako, Kumi Oshima, Miki Sato, Kiriko Terasako, Shinya Okuda, Hideki Nakasone, Rie Yamazaki, Yukie Tanaka, Aki Tanihara, Yutaka Kawamura, Hirokazu Kiyosaki, Takakazu Higuchi, Junji Nishida, Fumio Konishi, Yoshinobu Kanda

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The clinical features and outcome of small intestinal lymphoma remain unclear. We retrospectively analyzed 23 patients who had non-Hodgkin lymphoma with a small intestinal lesion. With a median follow-up of 37 months, the 5-year overall survival and failure-free survival (FFS) were 64% and 60%, respectively. In a univariate analysis, a worse performance status at the start of treatment and the occurrence of abdominal symptoms or perforation during treatment were associated with poor survival. Perforation often resulted in a dismal prognosis in patients with uncontrollable lymphoma, but not in patients with lymphoma in remission. The role of surgery in small intestinal lymphoma remains equivocal. In the current study, surgery before other therapies favorably influenced FFS, and all patients who underwent complete resection of the small intestinal lesion had extremely favorable results. Further studies are warranted to establish optimal therapeutic strategies.

Original languageEnglish
Pages (from-to)1618-1624
Number of pages7
JournalLeukemia and Lymphoma
Volume50
Issue number10
DOIs
Publication statusPublished - 2009 Nov 11
Externally publishedYes

Fingerprint

Non-Hodgkin's Lymphoma
Lymphoma
Survival
Therapeutics

Keywords

  • Abdominal symptoms
  • Perforation
  • Small intestinal lymphoma
  • Surgical procedure

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Kako, S., Oshima, K., Sato, M., Terasako, K., Okuda, S., Nakasone, H., ... Kanda, Y. (2009). Clinical outcome in patients with small intestinal non-Hodgkin lymphoma. Leukemia and Lymphoma, 50(10), 1618-1624. https://doi.org/10.1080/10428190903147629

Clinical outcome in patients with small intestinal non-Hodgkin lymphoma. / Kako, Shinichi; Oshima, Kumi; Sato, Miki; Terasako, Kiriko; Okuda, Shinya; Nakasone, Hideki; Yamazaki, Rie; Tanaka, Yukie; Tanihara, Aki; Kawamura, Yutaka; Kiyosaki, Hirokazu; Higuchi, Takakazu; Nishida, Junji; Konishi, Fumio; Kanda, Yoshinobu.

In: Leukemia and Lymphoma, Vol. 50, No. 10, 11.11.2009, p. 1618-1624.

Research output: Contribution to journalArticle

Kako, S, Oshima, K, Sato, M, Terasako, K, Okuda, S, Nakasone, H, Yamazaki, R, Tanaka, Y, Tanihara, A, Kawamura, Y, Kiyosaki, H, Higuchi, T, Nishida, J, Konishi, F & Kanda, Y 2009, 'Clinical outcome in patients with small intestinal non-Hodgkin lymphoma', Leukemia and Lymphoma, vol. 50, no. 10, pp. 1618-1624. https://doi.org/10.1080/10428190903147629
Kako S, Oshima K, Sato M, Terasako K, Okuda S, Nakasone H et al. Clinical outcome in patients with small intestinal non-Hodgkin lymphoma. Leukemia and Lymphoma. 2009 Nov 11;50(10):1618-1624. https://doi.org/10.1080/10428190903147629
Kako, Shinichi ; Oshima, Kumi ; Sato, Miki ; Terasako, Kiriko ; Okuda, Shinya ; Nakasone, Hideki ; Yamazaki, Rie ; Tanaka, Yukie ; Tanihara, Aki ; Kawamura, Yutaka ; Kiyosaki, Hirokazu ; Higuchi, Takakazu ; Nishida, Junji ; Konishi, Fumio ; Kanda, Yoshinobu. / Clinical outcome in patients with small intestinal non-Hodgkin lymphoma. In: Leukemia and Lymphoma. 2009 ; Vol. 50, No. 10. pp. 1618-1624.
@article{bccffe7018b74b4c8d999d047ee96dae,
title = "Clinical outcome in patients with small intestinal non-Hodgkin lymphoma",
abstract = "The clinical features and outcome of small intestinal lymphoma remain unclear. We retrospectively analyzed 23 patients who had non-Hodgkin lymphoma with a small intestinal lesion. With a median follow-up of 37 months, the 5-year overall survival and failure-free survival (FFS) were 64{\%} and 60{\%}, respectively. In a univariate analysis, a worse performance status at the start of treatment and the occurrence of abdominal symptoms or perforation during treatment were associated with poor survival. Perforation often resulted in a dismal prognosis in patients with uncontrollable lymphoma, but not in patients with lymphoma in remission. The role of surgery in small intestinal lymphoma remains equivocal. In the current study, surgery before other therapies favorably influenced FFS, and all patients who underwent complete resection of the small intestinal lesion had extremely favorable results. Further studies are warranted to establish optimal therapeutic strategies.",
keywords = "Abdominal symptoms, Perforation, Small intestinal lymphoma, Surgical procedure",
author = "Shinichi Kako and Kumi Oshima and Miki Sato and Kiriko Terasako and Shinya Okuda and Hideki Nakasone and Rie Yamazaki and Yukie Tanaka and Aki Tanihara and Yutaka Kawamura and Hirokazu Kiyosaki and Takakazu Higuchi and Junji Nishida and Fumio Konishi and Yoshinobu Kanda",
year = "2009",
month = "11",
day = "11",
doi = "10.1080/10428190903147629",
language = "English",
volume = "50",
pages = "1618--1624",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "10",

}

TY - JOUR

T1 - Clinical outcome in patients with small intestinal non-Hodgkin lymphoma

AU - Kako, Shinichi

AU - Oshima, Kumi

AU - Sato, Miki

AU - Terasako, Kiriko

AU - Okuda, Shinya

AU - Nakasone, Hideki

AU - Yamazaki, Rie

AU - Tanaka, Yukie

AU - Tanihara, Aki

AU - Kawamura, Yutaka

AU - Kiyosaki, Hirokazu

AU - Higuchi, Takakazu

AU - Nishida, Junji

AU - Konishi, Fumio

AU - Kanda, Yoshinobu

PY - 2009/11/11

Y1 - 2009/11/11

N2 - The clinical features and outcome of small intestinal lymphoma remain unclear. We retrospectively analyzed 23 patients who had non-Hodgkin lymphoma with a small intestinal lesion. With a median follow-up of 37 months, the 5-year overall survival and failure-free survival (FFS) were 64% and 60%, respectively. In a univariate analysis, a worse performance status at the start of treatment and the occurrence of abdominal symptoms or perforation during treatment were associated with poor survival. Perforation often resulted in a dismal prognosis in patients with uncontrollable lymphoma, but not in patients with lymphoma in remission. The role of surgery in small intestinal lymphoma remains equivocal. In the current study, surgery before other therapies favorably influenced FFS, and all patients who underwent complete resection of the small intestinal lesion had extremely favorable results. Further studies are warranted to establish optimal therapeutic strategies.

AB - The clinical features and outcome of small intestinal lymphoma remain unclear. We retrospectively analyzed 23 patients who had non-Hodgkin lymphoma with a small intestinal lesion. With a median follow-up of 37 months, the 5-year overall survival and failure-free survival (FFS) were 64% and 60%, respectively. In a univariate analysis, a worse performance status at the start of treatment and the occurrence of abdominal symptoms or perforation during treatment were associated with poor survival. Perforation often resulted in a dismal prognosis in patients with uncontrollable lymphoma, but not in patients with lymphoma in remission. The role of surgery in small intestinal lymphoma remains equivocal. In the current study, surgery before other therapies favorably influenced FFS, and all patients who underwent complete resection of the small intestinal lesion had extremely favorable results. Further studies are warranted to establish optimal therapeutic strategies.

KW - Abdominal symptoms

KW - Perforation

KW - Small intestinal lymphoma

KW - Surgical procedure

UR - http://www.scopus.com/inward/record.url?scp=70350784070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350784070&partnerID=8YFLogxK

U2 - 10.1080/10428190903147629

DO - 10.1080/10428190903147629

M3 - Article

C2 - 19672778

AN - SCOPUS:70350784070

VL - 50

SP - 1618

EP - 1624

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 10

ER -